Stock listing

ALNOV Stock Price, News, Filings & Events — Novacyt Sas

Selected listing: ALNOV · EURONEXT · EUR · FR

This page tracks Novacyt Sas's ALNOV:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALNOV:EURONEXT. ALNOV:EURONEXT is the stock-level entry point for investors researching Novacyt Sas, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Novacyt Sas, traded under the ticker ALNOV, is a public company based in France with a market capitalization of approximately €38.2 million. The company is involved in the biotechnology sector, focusing on the development and commercialization of diagnostic solutions. Novacyt aims to provide innovative products that address critical healthcare needs.

ALNOV:EURONEXTEURFRUpdated September 5, 2026
Novacyt Sas logo
Ticker
ALNOV:EURONEXT
Asset type
Stock
Market cap
$42.7M
Sector
Health Technology
Industry
Medical Specialties
Exchange
EURONEXT
Currency
EUR

Novacyt Sas ALNOV:EURONEXT stock context

This page tracks Novacyt Sas's ALNOV:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALNOV:EURONEXT. ALNOV:EURONEXT is the stock-level entry point for investors researching Novacyt Sas, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Novacyt Sas, traded under the ticker ALNOV, is a public company based in France with a market capitalization of approximately €38.2 million. The company is involved in the biotechnology sector, focusing on the development and commercialization of diagnostic solutions. Novacyt aims to provide innovative products that address critical healthcare needs.

Latest news from Novacyt Sas

All Novacyt Sas news →

Novacyt Sas earnings calls

Research Novacyt Sas

Alternate listings